Transplantation

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDICAL FRONTIERS - 24th International Congress of the Transplantation Society

Optimizing Immunosuppression Adherence to Improve Long-term Graft Function

Berlin, Germany / July 15-19, 2012

Berlin - Long-term outcomes following transplantation have improved since the early 1980s but challenges remain, including increasing recipient and donor age as well as growing use of expanded criteria donors, all of which impact graft...

MEDICAL FRONTIERS - American Transplant Congress

Evaluating Strategies to Extend and Maximize Patient and Graft Survival

Boston, Massachusetts / June 2-6, 2012

Boston - For initial maintenance therapy following transplantation, guidelines recommend first-line use of calcineurin inhibitors (CNIs) with an antiproliferative agent, with or without steroids. However, experts now strive to achieve...

PRIORITY PRESS - 18th Annual International Congress of the International Liver Transplantation Society

Simultaneous Antiviral and Immunosuppressive Treatment Strategies in Liver Transplantation

San Francisco, California / May 16-19, 2012

San Francisco - Long-term outcome of patients undergoing liver transplantation as a result of the complications of hepatitis C viral (HCV) infection is predicted to improve with studies demonstrating that immunosuppressive drugs can be used...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 15th Congress of the European Society for Organ Transplantation

Improving Long-term Renal Graft Survival

Glasgow, UK / September 4-7, 2011

Reviewed and edited by: Jeffrey S. Zaltzman, MD, FRCPC Director, Renal Transplant, St. Michael’s Hospital, Associate Professor of Medicine, Division of Nephrology, University of Toronto, Toronto, Ontario Causes of Graft...

PRIORITY PRESS - 17th Congress of the International Liver Transplantation Society (ILTS)

Simplifying Immunosuppression for Liver Transplant Recipients: A Lifelong Commitment to Optimize Patient and Graft Survival

Valencia, Spain / June 22-25, 2011

Valencia - Following organ transplantation, anti-rejection drug efficacy is critical to optimal patient and graft survival but so, too, are tolerability and ease of administration. The calcineurin inhibitors (CNIs) have a long track record...

PRIORITY PRESS - 13th International Myeloma Workshop

Increasing Response and Reducing Adverse Events: An Exploration of Dosing Schedules and Combination Therapies for Multiple Myeloma

Paris, France / May 3-6, 2011

Paris - Proteasome inhibitor-containing regimens have improved response rates and response duration across all disease stages of multiple myeloma (MM) in transplant-eligible and -ineligible patients. New data presented here at the Myeloma...

MEDICAL FRONTIERS - American Transplant Congress

Simplifying Immunosuppression Regimens Post-Transplantation

Philadelphia, Pennsylvania / April 30-May 4, 2011

Incremental Gains in Renal Transplantation Organ transplantation, made possible by effective strategies to prevent rejection, has been one of the major success stories in medicine over the past several decades. Due to incremental...

PRIORITY PRESS - 37th Annual Meeting of the European Group for Blood and Marrow Transplantation

Stem Cell Transplantation: Prevention of Invasive Fungal Infections with Primary and Secondary Prophylaxis

Paris, France / April 3-6, 2011

In the early 1990s, allogeneic stem cell transplantation (SCT) recipients experienced improved survival with anti-Candida prophylaxis. However, the medical community observed a subsequent increase in mould infections, most notably invasive...

MEDICAL FRONTIERS - 23rd International Congress of the Transplantation Society

Perspective on Once-daily Immunosuppressive Therapy

Vancouver, British Columbia / August 15-19, 2010

Vancouver - Following organ transplantation, monitoring for optimal drug blood levels of immunosuppressive therapy is important, as lower levels may reduce efficacy while peaks in drug levels may carry an increased risk of toxicity. While a...

MEDICAL FRONTIERS - 2010 Congress of the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)

Controlling Hyperphosphatemia in Patients with Chronic Kidney Disease

Munich, Germany / June 25-28, 2010

Munich - Even between non-calcium-containing agents, phosphate binders used in dialysis patients appear to differ substantially. While these differences are now being closely evaluated for their influence on outcome, the attention generated...

PAGE 1 OF 4   1 2 3 4